NewsRx

Search our medical news database

Cancer Gene Therapy (Breast)

IL-15 Boosts Systemic Immunity against B7-1 Gene Transfected Breast Cancer Cells

Published in Vaccine Weekly, July 22nd, 1996

Interleukin-15 (IL-15), in cooperation with B7-1, induces immunity against a nonimmunogenic human breast cancer.

Many cancers are nonimmunogenic. Research has shown that the addition of a costimulatory molecule to cancer cells by gene transfection can help stimulate host immunity against the newly transfected cell.

The immune stimulating success of B7-1 gene transfection into nonimmunogenic tumor cells in animal models has led researchers to attempt this approach as an immunotherapeutic in nonimmunogenic human cancers.

J.Y. Djeu and colleagues from the University of Southern Florida College of Medicine submitted the results of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook